Cambridge researchers are harnessing the latest developments in science and technology to help us predict, diagnose and treat cancers at an ever earlier stage.
A multi-disciplinary centre of excellence which aims to bring cutting-edge pancreatic research from the bench to the bedside is launched.
Having diabetes in mid-life may reduce a person’s life expectancy by an average of six years, according to a large, multinational study coordinated...
A novel mechanism of cell death that occurs in mammalian organisms has been revealed by researchers at the University of Cambridge.
Patients who have benefited from life saving experimental cancer treatments will join world class researchers for a public open day.
<p>Research paves way for new liver disease research and possibly cell-based therapy.<br /> &nbsp;
Cambridge scientists are employing fragment-based drug discovery approaches - a technique that involves "growing" potent drugs from tiny chemical...
Researchers in the Department of Pathology have established precisely how the ‘cutting and pasting’ of genetic material from one chromosome to...
Cambridge scientists are asking what role stem cells play in how cancer develops, spreads and relapses.
Can better decisions be made about which anticancer drugs to progress to clinical trials?
Scientists at Strangeways Research Laboratory are leading the search for the ‘genetic cards’ that determine an individual’s risk of cancer.
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.
Cancer cells can now be viewed as never before, thanks to cutting-edge imaging tools being developed in Cambridge.
© 2021 University of Cambridge